Hydrocephalus
128
23
32
44
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
10.9%
14 terminated out of 128 trials
75.9%
-10.7% vs benchmark
7%
9 trials in Phase 3/4
20%
9 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (128)
Hyperfine Portable MRI in Hydrocephalus and Other Conditions Prompting Outpatient Brain Imaging
Assessment of CSF Shunt Flow During Activities of Daily Living and Sleep With a Thermal Measurement Device
Magnetic Resonance Elastography in Hydrocephalus
Role of Endoscopic Third Ventriculostomy Imanagement of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome
Study of Shunt Flow Under Different Valve Settings Using a Wireless Sensor
Combined Flow and Pressure Study of Craniospinal Dynamic
Strategies for Weaning From External Ventricular Drainage
Ultrasound (US) Guided External Ventricular Catheter Placement
UVC in Prevention of Surgical Wound Infection
Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants
European Study of Prodromal iNPH
Efficacy and Cost-Effectiveness of Topical Vancomycin Powder in Preventing Pediatric Ventriculoperitoneal Shunt Infections Across Different Etiologies
Neurosurgical Outcome Network
EVD Drainage Data and Intracranial Pressure (ICP) Measurements
Improving Infant Hydrocephalus Outcomes in Uganda
The ETCHES I Study (Endovascular Treatment of Communicating Hydrocephalus With an Endovascular Shunt)
Shunt-dependency After aSAH - Role of Early Hyperglycaemia in CSF and Blood
Flow Detection in Open and Closed Shunt Valve Periods
MiDura-Study (Neuro-Patch in Duraplasty)
Pilot Study of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus